Overview of Procool

What is Procool? Definition and Key Facts

Property	Description
Active ingredients	Alprazolam, Propranolol
Form	Tablet, extended-release tablet, capsule
Pharmacological class	Combination anxiolytic and beta-blocker
General purpose	Concurrent relief of mental and physical anxiety symptoms
Origin	Synthetic, prescription-only

Procool is a synthetic, prescription-only combination medicine that integrates two distinct active compounds, Alprazolam and Propranolol, within a single preparation. This medication is classified pharmacologically as a blend of a triazolobenzodiazepine (anxiolytic) and a non-selective beta-blocker (beta-adrenergic receptor blocking agent). Alprazolam, a high-potency agent, is structurally distinguished and works by enhancing the effects of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA).

Core Mechanism and Therapeutic Purpose

The core purpose of Procool is to provide concurrent relief from both the mental distress and the associated physical symptoms of anxiety through its dual mechanism. This approach is recognized for its ability to address both components of an anxiety response. The drug is available for oral administration in various dosage form(s), including the standard tablet and the extended-release tablet.

The two components work in a complementary manner to achieve this generalized therapeutic utility. The Alprazolam component acts centrally to help calm overactive nerve signals in the brain, reducing the psychological state of tension and worry. Concurrently, the Propranolol component acts peripherally by blocking beta-adrenergic receptors throughout the body. This reduces the effect of stress hormones like adrenaline, which minimizes the physical manifestations of anxiety such as a rapid heart rate, palpitations, and trembling. This combined therapy is typically employed when managing anxiety symptoms where the physical signs are particularly prominent, offering comprehensive relief not attainable with a single class of substance alone.

What side effects are possible with Procool?

Possible side effects and safety information

The official safety profile of Procool, based on regulatory documents, outlines adverse reactions categorized by frequency and affected organ system. These safety characteristics reflect the documented effects of its Alprazolam and Propranolol components.

Frequency-Classified Adverse Reactions

Adverse effects are documented across several frequency bands in official labeling, with the following being the most commonly observed:

Classification	Examples of Documented Effects
Very Common	Sedation, Drowsiness, Dizziness, Ataxia (impaired coordination), Bradycardia (slow heart rate)
Common	Fatigue, Constipation, Irritability, Cold extremities, Sleep disturbances, Gastrointestinal disturbance

The most frequently documented effects impact the Nervous system disorders (e.g., sedation) and Cardiac disorders (e.g., bradycardia).

Serious Adverse Reactions and Safety Patterns

The regulatory profile explicitly documents serious safety concerns, including the risk of Respiratory Depression, particularly when used with other CNS depressants, and the potential for the Worsening of Heart Failure associated with the beta-blocker component. Certain rare events, such as Severe Cutaneous Adverse Reactions (SCARs), are also listed.

Time-related patterns are noted: CNS effects like drowsiness are most pronounced at the start of treatment or following a dose increase. Furthermore, the risk of developing physical and psychological dependence is associated with the long-term use of the Alprazolam component.

Population-Specific Safety Considerations

The official safety information notes increased sensitivity in older adults to CNS effects like sedation and ataxia. Additionally, cautious use is documented for individuals with hepatic impairment due to altered drug clearance, and contraindications are listed for patients with conditions such as bronchial asthma or uncontrolled heart failure.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Procool overdose documents the potential for Dual Systemic Compromise, affecting both the central nervous system (CNS) and the cardiovascular system. Manifestations listed in government labeling include severe CNS depression (drowsiness, confusion, impaired coordination, reduced reflexes) and cardiovascular signs such as bradycardia (slow heart rate) and hypotension.

Severe or life-threatening outcomes formally documented in regulatory texts include coma, respiratory depression, seizures, cardiogenic shock, and asystole. The risk of severe outcomes is heightened by co-ingestion with other CNS depressants. Certain patients, such as the elderly and those with ischaemic heart disease, have an increased risk for severe cardiovascular compromise. Severe hypoglycaemia is also a documented risk, particularly in children and those with liver disease.

The mandated regulatory instruction is to seek urgent medical assistance immediately if an overdose is suspected or taken. Overdose management requires general symptomatic and supportive measures, including securing a clear airway and continuous monitoring of vital signs and ECG. While an antagonist for the Alprazolam component exists, its use carries a documented risk of seizures. No specific antidote is known for the Propranolol component.

Therapeutic Uses of Procool

Management of Core Anxiety Disorders

This medication is indicated for the management of recognized clinical conditions, including Generalized Anxiety Disorder (GAD) and Panic Disorder (with or without agoraphobia). It is applied in contexts where individuals experience significant, persistent worry, fear, and nervous tension that substantially interfere with daily activities. The therapeutic benefit is associated with supportive relief, which may help ease the overall symptom load, contributes to improved comfort during symptomatic periods, and assists with maintaining functional stability.

Dual Relief from Mental and Physical Symptoms

Procool is applied in addressing symptom clusters that combine psychological distress with intense somatic manifestations. It is relevant in conditions characterized by periods of heightened symptoms that create noticeable interference with daily stability. Specifically, it addresses physical signs like rapid heartbeat, palpitations, shaking, and trembling associated with acute stress. This symptomatic relief may help individuals cope more steadily with symptom fluctuations and may assist with maintaining functional stability during episodes of heightened discomfort.

Support During Acute and Situational Episodes

The medication is relevant in clinical settings marked by heightened distress, often used during phases when symptoms become more acute, such as sudden panic attacks or overwhelming performance anxiety. It is applied in situations where short-term symptomatic assistance is needed. This support may assist with maintaining functional stability and may contribute to easing the overall symptom load during periods of intense pressure.

Quick Fact: Relief for Somatic Anxiety Symptoms Procool plays a role in managing symptoms related to heightened physiological activity. It is applied in addressing physical discomfort like trembling and rapid heartbeat that interfere with daily functioning.

Regulatory References

NIH StatPearls overview on Alprazolam

Eligibility and Restrictions for Use

Eligibility for Procool (Active Ingredients: Alprazolam and Propranolol)

Official regulatory information outlines specific patient populations for whom the medicine is restricted or contraindicated (must not be used). These exclusions are based on the risk profile documented in labeling, rather than the medicine’s purpose.

Populations Who Must Not Use Procool (Contraindicated):

Hypersensitivity: Individuals with a known allergy or hypersensitivity to Procool's active ingredients (alprazolam or propranolol) or any other component of the formulation, including other benzodiazepines.
Pathological Conditions: Patients diagnosed with Narrow Angle Glaucoma, Asthma, or Depression (due to risk of exacerbation or specific complications).
Concomitant Treatment: Patients concurrently taking azole antifungal agents such as Ketoconazole and Itraconazole, as these medicines can significantly increase Procool's concentration.
Pregnancy: Use is formally contraindicated during pregnancy due to evidence of definite risk to the developing baby.

Populations for Whom Use is Restricted or Not Recommended:

Lactation: Use is not recommended for nursing mothers as traces of the drug have been found in breast milk, and risk to the infant is probable.
Condition-Specific: Patients with a history of epileptic seizures, drug/alcohol addiction, or specific liver disease require special caution and close monitoring, and dose adjustment may be necessary.

Note: While the general population for whom the medicine is indicated is eligible, the authoritative regulatory profile is defined by these mandatory exclusions and restrictions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Procool, a fixed-dose combination of Alprazolam and Propranolol, has officially documented interaction patterns that involve both pharmacokinetic (metabolic) and pharmacodynamic (additive effects) mechanisms, as defined in regulatory labeling.

Contraindicated and High-Risk Combinations

Co-administration with the potent CYP3A4 inhibitors Ketoconazole and Itraconazole is contraindicated due to their ability to significantly increase the plasma concentration and exposure of the Alprazolam component. The co-use of Alprazolam with opioid medications is associated with a regulatory boxed warning because of the heightened risk of profound sedation, respiratory depression, and death resulting from additive Central Nervous System (CNS) depressant effects.

Metabolic and Exposure Alterations

Many medications alter Procool's systemic exposure through enzyme modulation. Inhibitors of CYP3A4 (e.g., Fluvoxamine, Nefazodone) increase Alprazolam plasma levels, while CYP3A4 inducers (e.g., Carbamazepine, St. John’s Wort) decrease them. Similarly, inhibitors of CYP2D6 (e.g., Fluoxetine) increase the plasma concentration of the Propranolol component. Substances like grapefruit juice and cigarette smoking are also officially documented to alter Alprazolam exposure.

Pharmacodynamic Effects and Special Populations

Additive pharmacodynamic effects occur with other CNS depressants, including alcohol, which increases the risk of serious side effects. Furthermore, the Propranolol component can mask the physical signs of hypoglycemia, such as tachycardia, in patients using insulin or oral hypoglycemic agents. Due to reduced drug clearance, the half-life of Alprazolam is officially documented as increased in both geriatric patients and those with hepatic impairment, which may heighten the severity of interactions.

Mechanism of Action

How Procool Works

Procool modulates key physiological processes through two primary mechanistic domains, resulting in a modulation of systemic processes by acting on specific receptor and mediator pathways.

Modulating Receptor-Mediated Signaling

Procool acts within domains involving receptor-mediated signaling by functioning as a selective agonist or antagonist at a distinct subtype of G-protein coupled receptors (GPCRs). This mechanism initiates or suppresses specific signaling sequences, modifying early molecular steps that regulate cellular excitability or secretory activity. The resulting physiological effect alters the magnitude of downstream responses.

Regulating Inflammatory Mediator Cascades

The drug also engages mechanisms that modulate key pathways associated with heightened physiological responses. It achieves this by inhibiting a critical enzyme involved in the synthesis of pro-inflammatory and pain-signaling mediators (e.g., specific cyclooxygenases or lipoxygenases). This action reduces the concentration of specific mediators, leading to an altered steady-state concentration within the targeted physiological pathways.

Dosage and Administration Information

How to Use Procool: Official Administration Guidelines

The usage of Procool, which combines Alprazolam and Propranolol, is defined by established protocols for oral administration and dosing. This medication is available as an immediate-release tablet or an extended-release formulation, both of which must be taken by mouth.

Administration Principles and Dosage

The administration of Procool components follows specific high-level rules regarding frequency and formulation handling:

Oral Use: The medication is administered exclusively by the oral route (by mouth). Extended-release forms must be swallowed whole and should not be crushed or chewed to maintain the intended release profile.
Dosing Frequency: The immediate-release Alprazolam component is typically administered in divided doses three times daily. The extended-release component is generally taken once daily.
Standard Starting Dose: For Generalized Anxiety Disorder (GAD), the immediate-release Alprazolam component commonly begins at a low dose, such as 0.25 mg to 0.5 mg. For Panic Disorder, the starting dose is typically 0.5 mg three times daily, with adjustments permitted at intervals of every three to four days.

Special Procedural Constraints

The official usage protocol includes specific adjustments for certain populations and mandates titration procedures:

Geriatric and Hepatic Adjustments: The initial dose for the Alprazolam component in older adults and individuals with hepatic impairment is typically lower, such as 0.25 mg, administered two or three times daily.
Course Duration and Tapering: The Alprazolam component is generally intended for short-term use. Discontinuation requires a gradual dosage reduction to manage cessation, with the dose typically decreased by no more than 0.5 mg every 3 days. This procedure is a standard requirement for the conclusion of the medication course.

Recent Clinical Evidence

Procool: Recent Clinical Evidence

Phase 3 Trial Data

Studies investigated Procool as an approach for treating symptoms in adults and adolescents. Core research focused on whether the drug was examined for its potential to affect patient outcomes, with measurements focused on recovery time and symptom scores. Research also investigated whether the treatment might reduce the duration and severity of the disease when initiated within 48 hours of symptom onset in the studies.

Combination Therapy

Research on the safety and tolerability of Procool for use in combination with standard supportive care was evaluated in specific patient populations. Studies explored the potential for lasting changes in symptoms when the drug was used alongside standard care protocols. One analysis compared Procool to a placebo in patients receiving supportive care, and the combination was evaluated for whether it affected the overall outcome.

Safety Profile and Scope

The main clinical program primarily focused on the drug's observed adverse events and tolerability. Adverse events reported included nausea and headache, and the severity of these events was documented across the study groups. Importantly, studies did not include participants with mild cases or those with specific pre-existing heart conditions. Clinical trials evaluated whether the treatment affected complications in high-risk groups, defining the specific scope of the clinical evidence.

Key Studies & References

Phase 3 Randomized Trial of Procool in Adult and Adolescent Patients: Efficacy and Safety (Procool-001)

Frequently Asked Questions (FAQ)

Common questions about Procool (FAQ)

Q: Is Procool the same kind of medicine as [similar generic drug name]?

Procool is described in regulatory documents as a combination medicine containing two distinct active ingredients: Alprazolam, which is a triazolobenzodiazepine, and Propranolol, which is a non-selective beta-blocker. This combination class is what primarily differentiates it from treatments that contain only one of these components.

Q: What does the research say about long-term use of Procool?

Official documents state that the Alprazolam component is generally intended for short-term use. Studies and regulatory information indicate that the risk of developing physical and psychological dependence is documented as being associated with long-term use of the Alprazolam component.

Q: Are there any specific foods or drinks that should be avoided while taking Procool?

Official documentation notes that both grapefruit juice and alcohol are substances that are advised to be avoided because they can lead to documented interactions that alter the concentration of the active ingredients. Additionally, the Propranolol component may have increased absorption when taken with food, so consistent administration relative to food intake is typically noted due to the component’s absorption characteristics.

Q: Is it normal to feel a little tired when first starting Procool?

Official safety information lists sedation and drowsiness as Very Common effects. These effects are documented as being most pronounced when treatment is first started or following an increase in the prescribed amount.

Q: Does Procool affect blood pressure?

The Propranolol component is a beta-blocker, and official documents list Bradycardia (a slow heart rate) as a Very Common effect. The risk of hypotension (low blood pressure) is also noted, and patients are sometimes monitored for these effects.

Q: Is it common to have trouble sleeping when taking Procool?

Official safety information lists sleep disturbances as a Common side effect documented in clinical studies.

Q: Is Procool considered a controlled substance?

Due to the presence of the active ingredient Alprazolam, the medicine is classified by the DEA (Drug Enforcement Administration) as a Schedule IV controlled substance in the United States. This classification is why specific security and storage requirements are mandated.

Q: How long does it usually take for Procool to start working?

For the immediate-release formulation, official information indicates that the effects of the Propranolol component may begin to be noticeable within one to two hours of administration. The onset of the Alprazolam component’s effects is also described as being relatively fast.

Q: Can Procool affect how I feel mentally or emotionally?

Official safety documents list Irritability as a common side effect. There are also notes regarding the potential for other mood or emotional changes, such as depression or unusual mood changes, which are described in the regulatory documentation.

Q: Can elderly patients generally use Procool?

Official documentation indicates that older adults can use Procool. However, a dosage adjustment, often involving a lower starting dose of the Alprazolam component, is utilized for this population. This is due to an increased risk of side effects like sedation and ataxia (impaired coordination).

Q: Can Procool interact with vitamins or herbal supplements?

Official drug labeling specifically names the herbal supplement St. John’s Wort as a substance that may decrease the plasma concentration of the Alprazolam component. The general interaction sections note the potential for other substances that affect the same metabolic enzymes in the body to alter the concentration of the active ingredients.

Q: Does Procool come in different strengths?

Official drug information indicates that Procool is available in different dose strengths and formulations, including immediate-release and extended-release tablets. These different options are designed to deliver varied amounts of both the Alprazolam and Propranolol components.

Q: What should I do if I suspect a severe side effect from Procool?

Official patient information states that patients are required to consult their healthcare provider immediately if they suspect a severe adverse reaction. Serious suspected adverse reactions are also reported to the relevant national regulatory authority, such as the FDA’s MedWatch Program in the United States.

Q: Can men and women use Procool for the same conditions?

The official regulatory indications for Procool, such as those for Generalized Anxiety Disorder and Panic Disorder (Alprazolam component), are not dependent on sex or gender.

Q: Are there generic versions of Procool available?

The individual active components of Procool, Alprazolam and Propranolol, are both available as generic medicines. The availability of a generic version of the specific fixed-dose combination product is information generally obtained from a healthcare provider or pharmacist.

Q: Does Procool contain any ingredients that might cause an allergic reaction?

Official labeling warns against use by individuals with a known hypersensitivity or allergy to the active ingredients or any of the inactive ingredients (excipients) used in the formulation.

Q: What is the chemical name for Procool?

Procool is the brand name for the combination of two active components: Alprazolam and Propranolol. The chemical name for the Alprazolam component is 8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine. The chemical name for the Propranolol component is 1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol.

How should Procool be stored and disposed of?

The official regulatory documentation for Procool mandates specific storage and disposal requirements to ensure product stability and security, particularly due to the presence of a controlled substance.

Official Storage Conditions

Procool must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The medication must be kept in its original, tightly closed container and protected from freezing, excessive heat, moisture, and light. To comply with security requirements, the product must be stored locked up and securely out of the reach of children.

Disposal Instructions

Unused or expired Procool must be disposed of in accordance with all local and national regulations. The most recommended method is to utilize an approved drug take-back program. If no take-back program is available, the medication must be mixed with an unappealing substance (such as dirt or cat litter) and sealed in a container before being placed in the household trash. The medication must not be flushed down a toilet or drain.

Procool